Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trials
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.17318
Abstract: Brodalumab, a fully human anti‐interleukin‐17 receptor A monoclonal antibody, has demonstrated superior efficacy and safety over ustekinumab as induction therapy for moderate‐to‐severe psoriasis. read more here.
Keywords: safety brodalumab; efficacy safety; brodalumab patients; brodalumab ... See more keywords
Comparable efficacy and safety of brodalumab in obese and nonobese patients with psoriasis: analysis of two randomized controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Dermatology"
DOI: 10.1111/bjd.18327
Abstract: Obesity is associated with psoriasis and negatively affects response to therapy. read more here.
Keywords: brodalumab obese; safety brodalumab; nonobese patients; efficacy safety ... See more keywords